logo

Remus Pharmaceuticals Ltd. Financials

15:51 May 30

Remus Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
2088.50
+52.80 (+2.59%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Remus Pharmaceuticals Ltd. Financials

Remus Pharmaceuticals Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
2088.50
+52.80 (+2.59%)
15:51 May 30
Quality
image/svg+xml

0/100
Not Eligible

Valuation
image/svg+xml

11/100
Expensive Valuation

Technical

48/100
Technically Neutral

Strength

2

Weakness

2

Opportunity

0

Threats

0

11.36 %

ROE %

6.71 %

ROA %

49.34

EPS

434.40

BVPS

4.68 %

Net Profit Margin

Mar 2024 Mar 2025
Net Sales
212.5 620.36
Operating Expenses +
184.69 574.67
Raw Material
164.99 541.31
Increase Decrease in Cost
-0.67 -8.44
Other Manufacturing Expense
0 0
Employee Cost
7.42 13.11
Miscellaneous Expenses
342.93 1111.31
Operating Profit
27.81 45.69
Other Income
5.4 4.98
Depreciation
0.9 1.87
Interest
0.48 1.46
Profit before tax and exceptio..
31.83 47.34
Exceptional Items
0 0
PBT
31.83 47.34
Provision for Taxation
5.85 8.92
Net Profit
25.98 38.42
NET Profit after MI
25.98 29.07
EPS
152.01 65.21
Operating Profit Margin (%)
13.09 7.37
Net Profit Margin (%)
12.23 4.69

Remus Pharmaceuticals Ltd. Shareholding

Promoter

FII

Public

Mutual Funds

Other Institutions

All Data in Percentage (%)

Mar 25 Sep 24 Mar 24
Promoter 70.80 70.80 70.60
FII 4.80 3.20 3.20
MF 0.00 0.00 0.00
Public 23.60 25.20 25.50
Others 0.10 0.10 0.00
Others 0.70 0.70 0.70
Shareholder Shares Holding %
Research 360 logo
Download Our App On: